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Abstract
BALB/c mice injected at birth with 108 semi-allogeneic (C57BL/6 x BALB.IgHb)F, spleen cells
develop a lupus-like syndrome In which autoantibodles bear exclusively the donor allotype. We
have analyzed the evolution of donor B cell chlmerlsm and the autoimmune manifestations
during the first year of life in these mice. Antl-DNA, -histone, and -cardlollpln IgG antibodies as
well as circulating immune complexes appeared in the second week of life, reached the highest
values around the sixth week, and then progressively dropped to normal values after the sixth
month in most mice. The kinetics of the evolution of the autoimmune manifestations, as well as
the kinetics of serum donor Ig allotype, were parallel to the kinetics of donor B cell chlmerism,
which was particularly prominent in the spleens in early weeks of life, and progressively
decreased after remission of the autoimmune syndrome. Membrane-proliferative
glomerulonephritls, which was followed as the more representative hlstological abnormality in
this model, was particularly evident after 10 weeks of life, but disappeared by the end of the
follow-up. Interestingly, when mice with a self-limited disease were re-injected with 108 F, spleen
cells i.v., a flare in the serologlcal manifestations was observed. In these re-injected mice a
predominance of anti-DNA, lgG1 antibodies bearing exclusively the donor allotype was also
observed, as in the early weeks of life. These results emphasize the central role of donor B cell
chimerism in the development and in the self-limitation of the autoimmune disease in parental
mice neonatally injected with F, cells and Indicate that the capacity to react with F, cells,
to generate a renewed burst of symptoms, persists in these mice after the disappearance
of autoimmune findings.
Introduction
Although spontaneous models of mouse systemic lupus
erythematosus (SLE), such as NZB/W, MRU/pr, or BXSB, have
been widely studied (1,2), experimentally-induced models of SLE
have received less attention. Recently, it has been reported that
BALB/c mice injected at birth with semi-allogeneic (C57BL/6 x
BALB.IgHb)F, spleen cells develop a SLE-like disease
consisting of hypergammaglobulinemia, with production of
several autoantibodies, circulating immune complexes (CICs),
lymphosplenomegaly, thrombocytopenia, and glomerulonephritis
(3). Previous studies on the immune mechanisms responsible
for the autoimmune syndrome observed in mice neonatally
injected with F, cells have demonstrated that autoantibodies are
only produced by donor B cells (4) and that host CD4+ T cells
are necessary for donor B cell activation, whereas donor CD4+
T cells are not (5-8).
In lupus-prone mice, abnormal levels of autoantibodies
and CICs begin to be detectable after 2 months of life and
progressively increase, leading in most cases to death due to
glomerulonephritis (GMN) (9-11). Murine models of graft versus
host disease present a broad range of serological abnormalities,
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varying from hypogammaglobulinemia, in close relation to
hypoplastic syndrome, to autoimmune manifestations associated
with lymphoprohferative and collagen-vascular disease (12). In
contrast with classical experimental murine models of autoim-
mune disease, the kinetics of autoantibody production and evolu-
tion of GMN, considered as the most representative histological
lesion (3), has not been established in this model of SLE-like
disease.
The aim of this study was to characterize the long-term
evolution of the autoantibody pattern and autoimmune lesions
developed in mice neonatally injected with F, cells. Considering
the central role of donor B cells in this model, we have also
analyzed the kinetics of donor T and B lymphocyte chimerism
in different lymphoid organs. Here we present evidence of a
progressive decrease of donor B cell chimerism that correlates
with the evolution of serum autoantibody titers and the
self-limitation of the autoimmune syndrome. In addition, the
production of autoanti bodies was re-activated by the re-injection
of F, B cells into adult neonatally injected mice that had
manifested a self-limited autoimmune disease.
Methods
Mice
BALB/c and C57BU6 mice were purchased from Charles
River (Spain). Congenic BALB.Ighb mice (lgCH-1b) were
kindly provided by the Walter & Elisa Hall Institute (Melbourne,
Australia). (C57BL/6 x BALB.IgHb)F, hybrid mice were
produced in our laboratory.
Injection of cells into neonatal mice
A cell suspension containing 108 spleen cells from 2 - 3 month
old (C57BL/6 x BALB.IgH^F, hybrid mice was i.p. injected into
newborn BALB/c (lgha) mice within 24 h after birth, as
previously described (5). Control mice were uninjected littermates.
Serum samples
Ether anesthetized mice were bled by retro-orbital sinus puncture
and blood was kept for 90 min at room temperature to clot. Then,
serum was separated by centrifugation at 1500 g for 10 mm and
stored at -70°C until use.
Determination of Ig allotype
To evaluate the levels of lghb allotype bearing Igs in the serum
of F, cell injected mice, a previously described (4) solid-phase
ELISA was employed using an alkaline phosphatase (AP)
conjugated anti-lghb allotype antiserum, obtained as previously
reported (13,14). Results were expressed in mg-equivalent/ml
of lghb bearing Ig from normal C57BL/6 serum.
Solid-phase anti-single-strand (ss) DNA assays
To measure anti-ssDNA IgG and IgG subclass antibodies, as well
as to determine the donor or host Ig allotype of these antibodies,
ELISA techniques were employed as described elsewhere (7).
Goat anti-mouse 7-chain specific antibody (Cappel Laboratories,
Cochranville, PA) and rabbit anti-mouse IgG subclass-specific
antibodies (Biometics Lab., Kensington, MD) were used as AP
conjugates. In addition, a mouse mAb specific for lgG2a-lghb
allotype (donated by Dr Van Snick, Ludwig Institute for Cancer
Research, Brussels) as well as anti-lgh3 and anti-lghb allotype
antisera, obtained as previously described (7), were conjugated
to AP and used in these experiments. Results are expressed in
titration units (TU) referred to a standard curve obtained by serial
dilutions of a serum pool obtained from 6 - 8 month old MRL
Ipr/lpr mice, except for anti-ssDNA lgG2a antibodies or for anti-
ssDNA antibodies bearing the lghb donor allotype, where a
serum pool obtained from 6 - 8 month old male BXSB mice was
used.
Anti-histone and anti-cardiolipin antibodies
An ELISA method was employed, similar to that used for
anti-ssDNA antibodies. Polystyrene microtiter plates (Limbro, Flow
Lab., McLean, VA) were coated with 50 y\ of total histones
(Boehringer-Mannheim 223565) diluted at 10/ig/ml in borate
buffer saline (pH 8.6) or with 50 /J of cardiolipin (Sigma Chemical
Co., St Louis, MO) diluted at 10 /tg/ml in absolute ethanol The
contamination of the histone preparation by DNA was < 1 % as
estimated by UV spectrophotometry at 260 nm. Plates with
cardiolipin were dried under nitrogen flow. For both assays sera
were diluted 1/100 in PBS, 1 % BSA, and 0.05% Tween-20. The
AP conjugate used was a goat anti-mouse 7-chain specific anti-
body (1 /ig/ml). Results are expressed in TU referred to a
standard curve obtained by serial dilutions of the same serum
pool of MRL Ipr/lpr mice used for anti-ssDNA antibodies, which
showed a strong antibody activity against these antigens.
CICs
The levels of CICs were determined by conglutinin binding
in solid phase, using an ELISA methodology as previously
described (5). Bovine conglutinin was obtained from normal adult
bovine serum, according to Maire etal. (15). Results are
expressed in /ig-equivalent by reference to a standard curve
obtained by serial dilutions of heat aggregated mouse IgG,
previously incubated for 45 min at 37°C with fresh normal mouse
serum as a source of complement.
Kidney studies
Kidneys previously fixed in 10% formaldehyde were embedded
in paraffin and 3 (im sections were processed with hematoxylin -
eosin stain, periodic acid-Schiff stain, and silver-metenamin
impregnation, according to standard methods (16). Tissue
binding of IgM, IgG subclasses, and C3 was assessed by
direct immunofluorescence on kidney cryocut sections (4 /*m)
using fluoresceinated rabbit anti-mouse IgM (Cappel) or a
rabbit anti-mouse IgG subclass specific antiserum (Southern
Biotechnology Associates, Birmingham, AL). The presence of
C3 was detected with a rabbit anti-rat C3 antibody, cross-reactive
with mouse C3 (Cappel).
Flow cytometry analysis
Cell frequencies were analyzed by flow cytometry using a
FACScan flow cytometer (Becton-Dickinson, Mountain View, CA)
with a Consort-30 (Hewlett-Packard 9000) computer set-up. The
following mAbs were used: RA3-2C2 (rat IgM anti-mouse B220)
(17), Bet-2 (rat IgM anti-mouse lgG1) (18), MB 86 (rat IgG
anti-mouse IgM13) (19), and Ig (5b) 6.3 (mouse lgG1 anti-mouse
IgD*3) (20). A 50 /tl aliquot of a previously determined optimal
dilution of these mAbs, conjugated to FITC or biotin, was
incubated for 30 min at 0°C with 5 x 105 viable cells, washed
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twice, and, on those biotinylated antibodies, the avidin-
phycoerythrin complex was added.
Determination of Ig allotype on culture supernatants
Spleen cells (10s) from 50 week old neonatally injected mice
were cultured in polystyrene plates with lipopdysaccharide (LPS)
(25 /tg/ml) for 5 days. Spleen cells from normal BALB/c mice were
also pulsed with LPS and used as controls. The presence of IgM
bearing the lghb allotype was analyzed using solid-phase ELISA
methodology. Briefly, plates were coated with the MB.86 anti-/ib
IgG mAb (10 /tg/ml) (19). Then, 50/d of undiluted culture
supernatant was added to the wells and incubated at room
temperature for 2 h. A polyclonal goat anti-mouse IgM (1 ^g/ml)
(Southern Biotechnology) was used as the AP conjugate. In
order to exclude rheumatoid factor activity, subsequent to LPS
stimulation, microtiter plates were coated with similar amounts
of an irrelevant mAB, instead of anti-/ib IgG mAb
Results
Experimental design
To study the kinetics of autoantibody production and kidney
lesions in parental mice neonatally injected with F, cells,
50 BALB/c mice, injected at birth with 108 (C57BU6 x
BALB.IgH^F, spleen cells, were bled weekly up to the third
week and then every 3 - 4 weeks until the 50th week of age.
Serum samples were tested for the presence of Igs bearing the
donor lghb allotype, anti-DNA, anti-histones, and anti-cardiolipin
IgG antibodies. The levels of CICs were also analyzed. At
1, 2, 4, 10, 15, 27, and 50 weeks of age, four to seven
neonatally injected mice were randomly killed for sequential
anatomopathological kidney studies. Single cell suspensions
of thymus, spleen, and lymph nodes were obtained at 4, 10,
16, 27, and 50 weeks of age for flow cytometry analysis.
Age-matched uninjected BALB/c mice were used as controls.
Transient donor Ig and autoantibody production in neonatally
injected mice
Igs bearing the donor lghb allotype were detected in 47 out of
50 neonatally injected mice. Since the presence of donor Igs
widely correlates with an effective induction of tolerance, in terms
of absence of allo-specific cytotoxic T cell activity (4), in this study
we analyzed the 47 mice in which donor Igs were demonstrated.
The highest levels of donor Igs in these mice were found in the
first 11 weeks of age and then a progressive decrease in their
titers was observed. At 50 weeks of age, donor Igs were
detectable only in three out of 13 mice and their levels were very
low (Fig. 1a).
We next explored the kinetics of autoantibody production. Anti-
DNA IgG antibodies were demonstrated in F, cell injected
BALB/c mice at 1 (25% of animals) and 2 (100%) weeks of age,
reaching the highest titers at 6 weeks in most mice (Fig. 1 b).
Thereafter, a sharp decrease in the titers of anti-ssDNA antibodies
was observed between 8 and 11 weeks of age. Most mice (15
out of 25) reached normal values before the sixth month of age
and only one out of 13 injected mice showed very low titers of
anti-DNA IgG antibodies at 50 weeks.
In order to evaluate the origin and nature of anti-DNA
antibodies in those neonataJly injected mice in which these
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Fig. 1. Follow-up of serum levels of donor allotype Igs (a), anti-ssDNA
IgG antibody (b), and anti-histone IgG antibodies (c) in BALB/c mice
injected at birth with 108(C57BL/6 x BALB.IgH^F, spleen cells (open
squares) Uninjected BALB/c mice were used as controls (closed
squares). Results are expressed in TU for anti-DNA and anti-histone
antibodies. Donor allotype is expressed in mg-equivalent/ml of equivalent
lghb-beanng IgG from normal C57BL/6 serum. SEMs are represented.
antibodies remained elevated after 20 weeks, their allotype and
IgG isotypes were analyzed. The data obtained showed that
anti-DNA antibodies in these mice bore only the lghb donor
allotype, but not the lgha host Ig allotype, indicating their
exclusive donor B cell origin (Fig. 2). Furthermore, they exhibit
predominantly the lgG1 isotype as observed in the early stages
of the autoimmune syndrome (4) (Fig. 3).
The evolution of anti-histone IgG antibodies was also studied.
Its profile was similar to that of anti-DNA IgG antibodies (Fig. 1c).
The highest levels were observed at 3 weeks; thereafter, the
titers of these antibodies decreased, reaching normal values
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Fig. 2. Serum levels of anti-DNA antibodies bearing the Iglr9 allotype
(left) or the lghb allotype (right). BALB/c mice (lgha allotype), injected at
birth with 106 (C57BL/6 x BALB IgH^F, (Igh1* allotype) spleen cells,
were sequentially bled and anti-DNA was measured in serum A group
of these mice, in which anti-DNA antibodies and CICs dropped to normal
values before 20 weeks of age were then i.v re-injected with 108
(C57BU6 x BALB IgH^F, spleen cells. Mice, unmiected at birth, that
received i v. injection of 10° (C57BU6 x BALB lgH°)F, spleen cells at
20 weeks of age served as control for this last group. ELISA results were
obtained on sera selected on the basis of the presence of anti-DNA IgG
antibodies, from the following groups of mice (1 )3 -6 week old injected
mice; (2) 20 -30 week old injected mice with persistent high titers of
anti-DNA antibodies at this age, and (3) 20 - 30 week old mice re-injected
with F, cells after self-limitation of their primary autoimmune syndrome.
Results are expressed in TU and represent the mean values obtained
in 15-20 sera per group. Discontinuous lines represent means + 3 SD
of the values obtained in age-matched uninjected BALB/c control mice.
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Fig. 3. Comparative levels of anti-DNA IgG subclasses in three different
groups of sera from BALB/c mice injected at birth with 108 (C57BL/6 x
BALB.IgH^F, spleen cells: (1) sera from 3 - 6 week old injected mice,
(2) sera from 20 - 30 week old injected mice with persistent high titers
of anti-DNA antibodies at this age; and (3) sera from 20-30 week old
mice re-injected with F, cells after self-limitation of their primary
autoimmune syndrome. Sera from 8 - 1 2 age-matched uninjected BALB/c
mice served as control in each group. Values represent the fold increase
of the titers, expressed in TU, as compared with the controls and express
the mean values of 12-15 sera per group.
Fig. 4. Examples of individual evolutions of three BALB/c mice (A- C)
injected at birth with 108 (C57BL/6 x BALB IgH^F, spleen cefls Results
are expressed in TU for anti-DNA (a) and anti-histone IgG (b) antibodies.
at 30 weeks of age in most mice. Furthermore, the titers of
anti-cardiolipin IgG antibodies and CICs showed a similar
evolution to the anti-DNA and anti-histone antibodies (data
not shown).
Regarding the individual evolution of autoantibodies and CICs,
two kinds of kinetics could be observed. (1) In most mice (20/32)
autoantibodies had a similar evolution to that described for the
whole group, with early sustained self-limitation of serological
markers during the first months of life, as illustrated in mouse A
of Fig. 4(a and b). (2) In the remaining mice, the kinetics were
diverse, with long-lasting autoantibodies and/or fluctuations in
the levels of the different serological markers during the study,
reaching normal titers several weeks later than in the previous
group. Two representative examples of these alternative patterns
are shown in mice B and C of Fig. 4(a and b).
Mortality rate and immune-pathological alterations in kidneys of
neonatally injected mice
We did not observe any significant difference in mortality rates
between injected and control mice during the length of the study.
Only three injected mice died spontaneously as a consequence
of the development of a non-Hodgkin polymorphic lymphoma.
In the kidneys, deposits of IgG, IgM, and C3 were seen at 2
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Table 1 . Kinetic study of Igs and C3 deposits in the glomeruli of injected mice
Immunofluorescence
staining
IgG
lgG1
lgG2b
lgG3
IgM
C3
Light microscopy13
1 st week
(n = 4)
0
0
0
0
0
0
N
2nd week
(n = 3)
+
+
0
0
+ +
+
N
4th week
(n = 2)
+ +
+
+ -
0
+
+ +
N
10th week
(n = 4)
+ + +
+ +
+
+
+ +
+ +
mGNM
27th week
(n = 4)
+ + + +
+ + +
+
+
+ + +
+ + +
aGNMd
50th week
(n = 6)
+
+
+
0
+ /+ +
+
Nc
aThe intensity of fluorescence was evaluated from 0 to + + + +.
bmGNM, minimum glomerulonephritis, aGNM, advanced glomerulonephritis, N, absence of pathological lesions
°One out of six mice analyzed had GMN.
dlt should be noted that, due to random selection, three out of six mice studied at 27 weeks still had active autoimmune disease, with increased
liters of autoantibodies and CICs.
weeks of age in the subendothehal capillary loops and in the
mesangium of injected mice. A progressive increase in granular
deposits was observed until the 27th week. In this respect, it
should be noted that three out of six mice killed at the 27th
week had active autoimmune disease with abnormal levels of
autoantibodies and CICs. Typical histological features of diffuse
prohferative GMN, with thickening of capillary loops, widening
of the matrix, and discrete increase in the number of mesangial
cells, were only seen after 10 weeks of age in these mice.
Thereafter, at the end of the follow-up, no significant histological
lesions were observed in kidneys by conventional microscopy,
in spite of the persistence of weak fluorescent deposits of IgG
in the mesangium (Table 1).
Kinetics of donor T and B cell chimerism in lymphoid organs
The frequencies of T and B cells of donor origin were studied
in injected mice by immunofluorescence and flow cytometry
analysis in single cell suspensions of thymus, spleen, and lymph
nodes obtained at 4, 10, 16, 27, and 50 weeks of age
In these F, cell injected mice the cell chimerism was more
evident and persistent in the spleen than in the thymus or lymph
nodes. Significant proportions of T and B cells of donor origin
were demonstrated in the spleen of injected mice in the early
weeks of age, reaching the highest values in the fourth week
(Table 2 and Fig. 5). Thereafter, a sharp decrease in the
frequency of donor T lymphocytes was seen, being undetectable
after 13 weeks of age, though a low number of donor B cells
was still detected at 27 weeks of age (Table 2). No evidence of
donor B cells was found in any of the spleen samples analyzed
at 50 weeks. However, when spleen cells from these 50 week
old F, cell injected mice were cultured in vitro for 5 days with
LPS, Igs bearing the donor lghb allotype were demonstrated in
the culture supernatants (data not shown). These data are
consistent with a steep decrease in donor B cell chimerism in
tolerant mice, with a small number of B cells persisting at very
low levels after the first year of life.
Evidence of T cell chimerism was found in lymph nodes of
neonatally injected mice at 4 weeks of age (10% of total lymphoid
cells) but not later ( < 1 % after 10 weeks of age). The smal
proportion of B cells in these organs did not allow an accurate
determination of the frequency of cells bearing surface Igs with
the donor allotype. With regard to the thymus, none of the
Table 2. Flow cytometry analysis of spleen cells (FACScan I),
using anti-allotype lghb (B cells) or anti-H2-Kb (T cells) mAbs"
B cells
donor
host
Total
T cells
donor
host
Total
Age
4
28
33
61
9
24
33
(weeks)
10
12
55
67
3
28
31
15
35
58.5
62
<1
29
29
27
2.2
62.8
65
ND
ND
ND
50
<1
62
62
ND
ND
ND
The mean of positive cells (%) from three to seven mice per group
is expressed.
samples analyzed after the third week of life showed a significant
amount of T lymphocytes bearing donor H-2b surface antigens.
Re-injection of F, cells in neonatally injected mice re-activates
the autoimmune syndrome
The data presented here suggest that a reduction in the number
of donor B cells could be responsible for the self-limitation of the
autoimmune syndrome observed in most of these mice. In order
to evaluate this hypothesis, 20 week old BALB/c mice, injected
at birth with 108 (C57BU6 x BALB.IgHb)F, spleen cells,
were followed up to the time that the levels of anti-DNA IgG
antibodies and CICs dropped to normal. Then, in three separate
experiments, groups of four or five mice were injected i.v. with
108 spleen cells from (C57BL/6 x BALB.IgH^F, mice. As
controls, age matched neonatally uninjected BALB/c mice were
also i.v. injected with 10s F, spleen cells.
In 10 out of 14 re-injected mice, a new increase in the levels
of donor Igs, and in the liters of anti-DNA antibodies (Fig. 6) and
CICs was observed. In the remaining four mice (which are not
represented in Fig. 6) none of these parameters were modified
after re-injection. The evolution of CICs as well as the levels of
Igs with the donor allotype after re-injection of F, spleen cells
in these mice was similar to that observed for anti-DNA IgG
antibodies (data not shown). By contrast, control BALB/c mice
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uninjected at birth, which received F, spleen cells at 20 weeks
of age, failed to develop significant levels of anti-DNA antibodies
(Fig. 6) and CICs.
The anti-DNA IgG antibodies observed in these F, cell
re-injected BALB/c mice had the same isotypic pattern
(predominance of IgG 1) found in the early and late stages of the
autoimmune syndrome (Fig. 3). In order to evaluate the origin
of the autoantibodies detected in these F, cell re-injected
BALB/c mice, the Ig allotype of the anti-DNA antibodies was also
studied. As represented in Fig. 2, only Igs bearing the lghb
donor allotype, but not those bearing the lgha host allotype,
showed anti-DNA reactivity.
By immunofluorescence, dense IgG and IgM deposits were
observed in the renal glomeruli of F, cell re-injected BALB/c
mice showing a burst in the autoantibody titers. Moderate IgG
and IgM deposits were also seen in kidneys from mice in
which re-injection of F, cells does not reinduce autoantibody
production. By contrast, no Ig deposits were observed in renal
glomeruli of BALB/c control mice that received a first injection
of F, cells at 20 weeks of age.
Discussion
We have shown that the injection of semi-allogeneic spleen cells
from (C57BL/6 x BALB.IgH^F, mice into parental newborn
BALB/c mice results in a self-limited autoimmune disease in which
a decrease in donor B cell chimerism is closely related to the
normalization of the serological autoimmune manifestations and
precedes by several months the clearance of glomerular Ig
deposits. Moreover, we have also shown that re-injection of F,
donor B cells in adult neonatally injected mice has a boosting
effect on the production of autoantibodies.
In this model, host CD4+ helper T cells that recognize
allogeneic class II molecules are known to be necessary for the
activation of autoreactive donor B cells (7,8,21), which are
uniquely responsible for the production of autoantibodies (4).
These donor B cells seem to be polyclonally activated through
an allogeneic interaction, as demonstrated in experiments using
hapten-carrier immunizations (4). A similar mechanism could be
claimed in experiments in which mouse helper T cells, specific
for B cell surface antigens, polyclonally activate in vitro a large
proportion of peripheral B cells independently of their actual
antigen specificities (22).
As compared with other experimental models of SLE, our
results show two distinctive features in the autoimmune
manifestations of these chimeric mice: (1) the production of
autoantibodies starts very early in life and uses preferentially the
lgG1 isotype, and (2) the syndrome is not life threatening due
to spontaneous abrogation of the serological and histological
manifestations of the disease in adult life. These data should shed
some light on the kinetics of cellular interactions involved in both
the triggering and the self-limitation of autoantibody production
in neonatally injected mice.
With regard to the triggering of the autoimmune syndrome,
there are three findings that merit special consideration. Firstly,
the autoantibody response uses predominantly the T helper-
dependent lgG1 isotype as early as the second week of life and
maintains this predominance in later stages. This observation
indicates that helper T cells from neonatally injected mice are
able to activate the Ig isotype switch in donor B cells very early
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week old BALB/c mouse neonatally injected with 10* (C57BL/6 x
BALB.IgH^F, spleen cells (right) or uninjected BALB/c mice as controls
(left). Cells were stained with fluorescein-labeled anti-IgM (Bet 2), anti-
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a FACScan flow cytometer. Data were acquired using FACScan Research
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(Becton-Dickinson). Background levels for green and red fluorescence
are indicated by continuous lines. Fluorescence intensity is represented
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(3
Z
Q
-L 200-
Age (week*)
Fig. 6. BALB/c mice, i.p. injected at birth with 108 (C57BU6 x
BALB.IgH^F, spleen cells were i.v. re-injected at 20 weeks of age with
the same dose of F, spteen cells ( • ) . As controls, urumanipulated
BALB/c mice ( • ) and BALB/c mice uninjected at birth but i.v. injected
at 20 weeks of age with lO^CSZBL/e x BALB.IgH^F, spleen celts ( • )
were used. The values of IgG anti-DNA antibodies are expressed in titra-
tion units and represent the mean values of 10 mice per group
in life and that a similar kind of cellular cooperation is maintained
through the length of the autoimmune syndrome. This fact seems
to be closely related with the pattern of lymphokine production
in parental mice neonatally injected with F, cells In this context,
it has recently been found that a 10-fold increase frequency
of IL-4 producing donor-allospecific T helper cells occurs in
neonatally injected mice, as compared with unmanipulated mice
(24; M. de la Hera era/., manuscript in preparation). Moreover,
treatment with anti-IL-4 mAb strongly decreased autoimmune
manifestations in these mice and cause a marked abrogation of
lgG1 autoantibody production (24).
Secondly, we show here that exclusively donor B cells appear
to be involved in the production of autoantibodies in three different
situations early and late stages of the autoimmune disease, and
after re-injection of F, cells in previously autoimmune mice.
These findings indicate that the host T helper activity on donor
B cells is very selective and does not involve autoreactive donor
B cells through a putative bystander help effect, as seems to
occur in some in vitro interactions (25). Our results are in
agreement with those of others (22,26) indicating that in vivo
interactions show no bystander effects, requiring a direct
recognition of antigen by helper T cells on the surface of B cells.
Thirdly, autoantibodies observed in neonatally injected mice
show marked differences from so-called natural autoantibodies.
Indeed, in addition to the lgG1 predominance, autoantibodies
of F, cell injected mice are not highly cross-reactive with
autoantigens (27, our unpublished observations), whereas
autoantbody repertoires of naturally activated autoreactive B cells
use predominantly the IgM isotype and show characteristic
cross-reactive specificities (28,29).
With respect to the spontaneous remission of the autoimmune
syndrome in adult life, we show direct evidence for the existence
of donor B cell chimerism in this model, which drops dramatically
with ageing. We also show that the progressive decrease in the
number of donor B cells in host lymphoid organs correlates well
with the disappearance of autoantibody production. Interestingly
enough, a new increase in autoantibody trters was observed upon
re-injection of F, B cells in some mice having a self-limitation of
their autoimmune syndrome. This effects seems to be due to a
donor B cell activation of similar characteristics to that observed
in neonatal mice, as suggested by the predominance of lgG1
autoantibodies and similar autoantibody kinetics. It should be
noted, however, that a burst of autoantibody production in adult
life only occurred in previously F, cell injected mice. All these
data strongly support the idea that the transient nature of the B
cell chimerism is a major mechanism for the self-limitation of
the autoimmune disease.
Nevertheless, the results presented here do not exclude the
possibility that other regulatory mechanisms could play a role
in the self-limitation of the disease In fact, after LPS stimulation
of spleen cells, antibodies produced by donor B cells were
demonstrated at 50 weeks of age, indicating that some donor
B cells are able to persist in F, cell injected mice without
evidence of autoimmunity. This finding suggests that additional
regulatory mechanisms might be involved in the autonomous
limitation of the disease. Moreover, the observation that, contrary
to most neonatally injected mice, some animals exhibit long
lasting autoimmunity, could suggest that individual variations in
such a putative control mechanism can allow different patterns
of autoimmune disease in neonatally injected mice. In this respect,
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CD8+ cytotoxic/suppressor T cells do not seem to play an
essential role in this model, because the in vivo depletion of this
T cell subset in neonatally injected mice was unable to modify
the evolution of the autoimmune syndrome or to induce a relapse
of the disease in mice with a previous self-limitation of their
autoimmune manifestations (6).
Moreover, the establishment of an active suppressor
mechanism seems improbable in view of the rapid rise of
autoantibodies and CICs after re-injection of F, B cells.
An alternative mechanism of functional inactivation (clonal
anergy) could be claimed to explain the self-limitation of the
autoimmune syndrome. Thus, it has recently been observed that
occupation of the T cell receptor can be followed by a signal
to down-regulate further antigen responsiveness (30). This
mechanism has also been involved in the induction of neonatal
tolerance to some superantigens, such as Mls-1a determinants
(31). However, the observation that re-injected donor B cells suffer
an allogeneic stimulation, similar to that observed in neonates,
indicates that this kind of regulation does not occur in our parental
neonatally injected mice. The fact that in these mice the IL-4
producer CD4+ subset (namely Th-2 cells) seems to be
responsible for the allogeneic stimulation of donor B cell (24) also
argues against this possibility, because this particular T cell subset
does not seem to be susceptible to the same down-regulation
mechanisms as the IL-2 producer Th-1 cells (32). These
re-injection experiments indicate that, in the neonatally injected
host, immunocompetent helper T cells specific for alloantigens
persist or are newly produced. In the thymus of 1 week old
neonatally injected mice, we have recently shown an absence
of specific T helper alloreactivity against the tderogen, with normal
response to third party H-2 disparate stimulator cells (21).
Conversely, a high specific T helper alloreactivity was detected
in the spleens of these mice. All these observations strongly
suggest that host alloreactive memory helper T cells could be
responsible for the activation of donor B cells re-injected in
parental neonatally injected mice.
Nevertheless, a question still remains unsolved: why do these
alloreactive T cells not activate the small resting donor B cell
population in spleens of F, cell injected mice with self-limited
autoimmune disease? One can argue that the very low number
of donor B cells present in adult non-autoimmune tolerant mice
(undetectable by flow cytometry) could be insufficient to interact
with the host T CD4+ cells. An increase in the number of
donor B cells, after their re-injection in neonatally injected
non-autoimmune mice, could then potentiate this interaction. In
any case, additional mechanisms of cellular control cannot be
excluded, although the rapid disappearance of donor T cells from
host lymphoid organs, when autoantibodies are still elevated,
seems to exclude these cells in such a control mechanism, being
consistent with the previously suggested view that donor T cells
play no significant role in this model (8).
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